BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10573790)

  • 41. What's new in enuresis?
    Eggert P
    Acta Paediatr Taiwan; 2002; 43(1):6-9. PubMed ID: 11890230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
    Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
    J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria.
    Hunsballe JM; Rittig S; Pedersen EB; Olesen OV; Djurhuus JC
    J Urol; 1997 Sep; 158(3 Pt 1):830-6. PubMed ID: 9258093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidiuretic hormone regulation in patients with primary nocturnal enuresis.
    Eggert P; Kühn B
    Arch Dis Child; 1995 Dec; 73(6):508-11. PubMed ID: 8546506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury.
    Zahariou A; Karagiannis G; Papaioannou P; Stathi K; Michail X
    Eura Medicophys; 2007 Sep; 43(3):333-8. PubMed ID: 17021585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circadian rhythm of water and solute excretion in nocturnal enuresis.
    Karamaria S; Dossche L; Delens V; Degraeuwe E; Raes A; Mauel R; Vande Walle C; Everaert K; Vande Walle J
    Pediatr Nephrol; 2023 Mar; 38(3):771-779. PubMed ID: 35748940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term treatment of nocturnal enuresis with desmopressin. A follow-up study.
    Knudsen UB; Rittig S; Nørgaard JP; Lundemose JB; Pedersen EB; Djurhuus JC
    Urol Res; 1991; 19(4):237-40. PubMed ID: 1926658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diuretic treatment of nocturnal enuresis.
    Nevéus T; Johansson E; Nydahl-Persson K; Peterson H; Hansson S
    Scand J Urol Nephrol; 2005; 39(6):474-8. PubMed ID: 16303723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circadian Rhythm of Glomerular Filtration and Solute Handling Related to Nocturnal Enuresis.
    Dossche L; Raes A; Hoebeke P; De Bruyne P; Vande Walle J
    J Urol; 2016 Jan; 195(1):162-7. PubMed ID: 26192252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic options in childhood nocturnal enuresis.
    Zaffanello M; Giacomello L; Brugnara M; Fanos V
    Minerva Urol Nefrol; 2007 Jun; 59(2):199-205. PubMed ID: 17571056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diurnal rhythm of urinary aquaporin-2 in children with primary monosymptomatic nocturnal enuresis.
    Abdelhamid N; Almawla MAA; Wahby AA; Ismail M; Elmikaty HA; Hamed HM; Ashmawy I; Abdelraoaf BM; Abdelhamid EM; Salam HM
    Turk J Med Sci; 2024; 54(1):194-203. PubMed ID: 38812639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of urine osmolality and ions in the pathogenesis of primary enuresis nocturna and in the prediction of responses to desmopressin and conditioning therapies.
    Unüvar T; Sönmez F
    Int Urol Nephrol; 2005; 37(4):751-7. PubMed ID: 16362593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of DDAVP on nocturnal enuresis in a patient with nephrogenic diabetes insipidus.
    Jonat S; Santer R; Schneppenheim R; Obser T; Eggert P
    Arch Dis Child; 1999 Jul; 81(1):57-9. PubMed ID: 10373137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of urodynamics in treatment of primary nocturnal enuresis persisting into adulthood.
    Yucel S; Kutlu O; Kukul E; Baykara M
    Urology; 2004 Nov; 64(5):1020-5; discussion 1025. PubMed ID: 15533498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diurnal anti-diuretic-hormone levels in enuretics.
    Nørgaard JP; Pedersen EB; Djurhuus JC
    J Urol; 1985 Nov; 134(5):1029-31. PubMed ID: 4057364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
    De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
    J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between desmopressin treatment and voiding pattern in children.
    Hvistendahl GM; Rawashdeh YF; Kamperis K; Hansen MN; Rittig S; Djurhuus JC
    BJU Int; 2002 Jun; 89(9):917-22. PubMed ID: 12010240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis.
    Eller DA; Homsy YL; Austin PF; Tanguay S; Cantor A
    Scand J Urol Nephrol Suppl; 1997; 183():41-5. PubMed ID: 9165605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of response to desmopressin in children and adolescents with monosymptomatic nocturnal enuresis.
    Rushton HG; Belman AB; Skoog S; Zaontz MR; Sihelnik S
    Scand J Urol Nephrol Suppl; 1995; 173():109-10; discussion 110-1. PubMed ID: 8719580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.